Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'NEGATIVE SYMPTOMS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1038 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Uberblick, E; Kathmann, N
      The neurocognitive basis of schizophrenic symptoms: a review

      ZEITSCHRIFT FUR KLINISCHE PSYCHOLOGIE UND PSYCHOTHERAPIE
    2. Bailer, J; Takats, I; Westermeier, C
      Efficacy of individualized cognitive-behavioral therapy for schizophrenic patients with negative symptoms and social disabilities: a controlled trial

      ZEITSCHRIFT FUR KLINISCHE PSYCHOLOGIE UND PSYCHOTHERAPIE
    3. Jeczmien, P; Levkovitz, Y; Weizman, A; Carmel, Z
      Post-psychotic depression in schizophrenia

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    4. Oosthuizen, P; Emsley, RA
      First-episode psychosis: lessons from 15 years of research

      PRIMARY CARE PSYCHIATRY
    5. Thaker, GK; Carpenter, WT
      Advances in schizophrenia

      NATURE MEDICINE
    6. Noordsy, DL; O'Keefe, C; Mueser, KT; Xie, HY
      Six-month outcomes for patients who switched to olanzapine treatment

      PSYCHIATRIC SERVICES
    7. Greene, R
      Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia

      HIPPOCAMPUS
    8. Bryden, KE; Carrey, NJ; Kutcher, SP
      Update and recommendations for the use of antipsychotics in early-onset psychoses

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    9. Lachar, D; Bailley, SE; Rhoades, HM; Espadas, A; Aponte, M; Cowan, KA; Gummattira, P; Kopecky, CR; Wassef, A
      New subscales for an anchored version of the Brief Psychiatric Rating Scale: Construction, reliability, and validity in acute psychiatric admissions

      PSYCHOLOGICAL ASSESSMENT
    10. Qiao, H; Noda, Y; Kamei, H; Nagai, T; Furukawa, H; Miura, H; Kayukawa, Y; Ohta, T; Nabeshima, T
      Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment

      NEUROREPORT
    11. Ovalle, S; Zamanillo, D; Andreu, F; Farre, AJ; Guitart, X
      Fibroblast growth factor-2 is selectively modulated in the rat brain by E-5842, a preferential sigma-1 receptor ligand and putative atypical antipsychotic

      EUROPEAN JOURNAL OF NEUROSCIENCE
    12. Troisi, A; Pasini, A; Spalletta, G
      Season of birth, gender and negative symptoms in schizophrenia

      EUROPEAN PSYCHIATRY
    13. Moritz, S; Andresen, B; Jacobsen, D; Mersmann, K; Wilke, U; Lambert, M; Naber, D; Krausz, M
      Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics

      EUROPEAN PSYCHIATRY
    14. Cuesta, MJ; Peralta, V
      Integrating psychopathological dimensions in functional psychoses: a hierarchical approach

      SCHIZOPHRENIA RESEARCH
    15. Suhr, JA; Spitznagel, MB
      Factor versus cluster models of schizotypal traits. I: A comparison of unselected and highly schizotypal samples

      SCHIZOPHRENIA RESEARCH
    16. Suhr, JA; Spitznagel, MB
      Factor versus cluster models of schizotypal traits. II: relation to neuropsychological impairment

      SCHIZOPHRENIA RESEARCH
    17. Silver, H; Shlomo, M
      Perception of facial emotions in chronic schizophrenia does not correlate with negative symptoms but correlates with cognitive and motor dysfunction

      SCHIZOPHRENIA RESEARCH
    18. Altamura, AC; Bassetti, R; Sassella, F; Salvadori, D; Mundo, E
      Duration of untreated psychosis as a predictor of outcome in first-episodeschizophrenia: a retrospective study

      SCHIZOPHRENIA RESEARCH
    19. Dreher, JC; Banquet, JP; Allilaire, JF; Paillere-Martinot, ML; Dubois, B; Burnod, Y
      Temporal order and spatial memory in schizophrenia: a parametric study

      SCHIZOPHRENIA RESEARCH
    20. Paillere-Martinot, ML; Caclin, A; Artiges, E; Poline, JB; Joliot, M; Mallet, L; Recasens, C; Attar-Levy, D; Martinot, JL
      Cerebral gray and white matter reductions and clinical correlates in patients with early onset schizophrenia

      SCHIZOPHRENIA RESEARCH
    21. Knott, V; Labelle, A; Jones, B; Mahoney, C
      Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment

      SCHIZOPHRENIA RESEARCH
    22. Naber, D; Moritz, S; Lambert, M; Rajonk, F; Holzbach, R; Mass, R; Andresen, B; Frank, P; Rudiger, H; Reinhard, M; Burghard, A
      Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs

      SCHIZOPHRENIA RESEARCH
    23. Meagher, D; Quinn, J; Murphy, P; Kinsella, A; Mullaney, J; Waddington, JL
      Relationship of the factor structure of psychopathology in schizophrenia to the timing of initial intervention with antipsychotics

      SCHIZOPHRENIA RESEARCH
    24. Peralta, V; Cuesta, MJ
      How many and which are the psychopathological dimensions in schizophrenia?Issues influencing their ascertainment

      SCHIZOPHRENIA RESEARCH
    25. Quinn, J; Meagher, D; Murphy, P; Kinsella, A; Mullaney, J; Waddington, JL
      Vulnerability to involuntary movements over a lifetime trajectory of schizophrenia approaches 100%, in association with executive (frontal) dysfunction

      SCHIZOPHRENIA RESEARCH
    26. Frodl, T; Meisenzahl, EM; Muller, D; Greiner, J; Juckel, G; Leinsinger, G; Hahn, H; Moller, HJ; Hegerl, U
      Corpus callosum and P300 in schizophrenia

      SCHIZOPHRENIA RESEARCH
    27. Winterer, G; Egan, MF; Radler, T; Hyde, T; Coppola, R; Weinberger, DR
      An association between reduced interhemispheric EEG coherence in the temporal lobe and genetic risk for schizophrenia

      SCHIZOPHRENIA RESEARCH
    28. Kurtz, MM; Ragland, JD; Bilker, W; Gur, RC; Gur, RE
      Comparison of the continuous performance test with and without working memory demands in healthy controls and patients with schizophrenia

      SCHIZOPHRENIA RESEARCH
    29. Jogems-Kosterman, BJM; Zitman, FG; Van Hoof, JJM; Hulstijn, W
      Psychomotor slowing and planning deficits in schizophrenia

      SCHIZOPHRENIA RESEARCH
    30. Salyers, MP; Mueser, KT
      Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia

      SCHIZOPHRENIA RESEARCH
    31. Nkam, I; Thibaut, F; Denise, P; Van Der Elst, A; Segard, L; Brazo, P; Menard, JF; Thery, S; Halbeck, I; Delamilleure, P; Vasse, T; Etard, O; Dollfus, S; Champion, D; Levillain, D; Petit, M
      Saccadic and smooth-pursuit eye movements in deficit and non-deficit schizophrenia

      SCHIZOPHRENIA RESEARCH
    32. Emsley, RA; Niehaus, DJH; Mbanga, NI; Oosthuizen, PP; Stein, DJ; Maritz, JS; Pimstone, SN; Hayden, MR; Laurent, C; Deleuze, JF; Mallet, J
      The factor structure for positive and negative symptoms in South African Xhosa patients with schizophrenia

      SCHIZOPHRENIA RESEARCH
    33. Meador-Woodruff, JH; Davis, KL; Haroutunian, V
      Abnormal kainate receptor expression in prefrontal cortex in schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    34. Kato, K; Shishido, T; Ono, M; Shishido, K; Kobayashi, M; Niwa, S
      Glycine reduces novelty- and methamphetamine-induced locomotor activity inneonatal ventral hippocampal damaged rats

      NEUROPSYCHOPHARMACOLOGY
    35. Scheepers, FE; de Wied, CCG; Pol, HEH; van de Flier, W; van der Linden, JA; Kahn, RS
      The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics

      NEUROPSYCHOPHARMACOLOGY
    36. Cavallaro, R; Mistretta, P; Cocchi, F; Manzato, M; Smeraldi, E
      Differential efficacy of risperidone versus haloperidol in psychopathological subtypes of subchronic schizophrenia

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    37. Vauth, R; Joe, A; Seitz, M; Dreher-Rudolph, M; Olbrich, H; Stieglitz, RD
      Differentiated short- and long-term effects of a "Training of emotional intelligence" and of the "Integrated psychologic therapy program" for schizophrenic patients?

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    38. Berner, P
      New concepts of schizophrenic sub-syndromes - Consequences for treatment

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    39. Klingberg, S; Buchkremer, G
      Cognitive behavioral treatment of schizophrenia - Ways towards differential indication

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    40. Herbener, ES; Harrow, M
      Longitudinal assessment of negative symptoms in schizophrenia/schizoaffective patients, other psychotic patients, and depressed patients

      SCHIZOPHRENIA BULLETIN
    41. Mueser, KT; Salyers, MP; Mueser, PR
      A prospective analysis of work in schizophrenia

      SCHIZOPHRENIA BULLETIN
    42. Johnson-Selfridge, M; Zalewski, C
      Moderator variables of executive functioning in schizophrenia: Meta-analytic findings

      SCHIZOPHRENIA BULLETIN
    43. Muller, MJ; Szegedi, A; Wetzel, H; Benkert, O
      Depressive factors and their relationships with other symptom domains in schizophrenia, schizoaffective disorder, and psychotic depression

      SCHIZOPHRENIA BULLETIN
    44. Allen, DN; Kelley, ME; Miyatake, RK; Gurklis, JA; van Kammen, DP
      Confirmation of a two-factor model of premorbid adjustment in males with schizophrenia

      SCHIZOPHRENIA BULLETIN
    45. Moriarty, PJ; Lieber, D; Bennett, A; White, L; Parrella, M; Harvey, PD; Davis, KL
      Gender differences in poor outcome patients with lifelong schizophrenia

      SCHIZOPHRENIA BULLETIN
    46. Roy, MA; Merette, C; Maziade, M
      Subtyping schizophrenia according to outcome or severity: A search for homogeneous subgroups

      SCHIZOPHRENIA BULLETIN
    47. Tattan, TMG; Creed, FH
      Negative symptoms of schizophrenia and compliance with medication

      SCHIZOPHRENIA BULLETIN
    48. Drapalski, AL; Rosse, RB; Peebles, RR; Schwartz, BL; Marvel, CL; Deutsch, SI
      Topiramate improves deficit symptoms in a patient with schizophrenia when added to a stable regimen of antipsychotic medication

      CLINICAL NEUROPHARMACOLOGY
    49. Ravert, HT; Mathews, WB; Klitenick, MA; Wong, DF; Dannals, RF
      Radiosynthesis of a ligand for studying the glycine transporter: [C-11]ALX-5407

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    50. Goethals, I; Audenaert, K; Van Laere, K; Van de Wiele, C; Dierckx, R
      Dopaminergic neurotransmission in psychiatry: should selection of patientsonly be based on DSM or ICD criteria?

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    51. Sachs, G; Katschnig, H
      Cognitive dysfunctions in schizophrenia - Medical and psychological treatment

      PSYCHIATRISCHE PRAXIS
    52. Lecrubier, Y; Azorin, M; Bottai, T; Dalery, J; Garreau, G; Lemperiere, T; Lisoprawski, A; Petitjean, F; Vanelle, JM
      Consensus on the practical use of amisulpride, an atypical antipsychotic, in the treatment of schizophrenia

      NEUROPSYCHOBIOLOGY
    53. Danos, P; Guich, S; Abel, L; Buchsbaum, MS
      EEG alpha rhythm and glucose metabolic rate in the thalamus in schizophrenia

      NEUROPSYCHOBIOLOGY
    54. Kaneda, Y; Fujii, A; Nagamine, I
      Platelet serotonin concentrations in medicated schizophrenic patients

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    55. Guillem, F; Bicu, M; Bloom, D; Wolf, MA; Desautels, R; Lalinec, M; Kraus, D; Debruille, JB
      Neuropsychological impairments in the syndromes of schizophrenia: A comparison between different dimensional models

      BRAIN AND COGNITION
    56. Wykes, T; van der Gaag, M
      Is it time to develop a new cognitive therapy for psychosis - Cognitive remediation therapy (CRT)?

      CLINICAL PSYCHOLOGY REVIEW
    57. Scheepers, FE; de Wied, CCG; Kahn, RS
      The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    58. Potkin, SG; Fleming, K; Jin, Y; Gulasekaram, B
      Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    59. Xiberas, X; Martinot, JL; Mallet, L; Artiges, E; Canal, M; Loc'h, C; Maziere, B; Paillere-Martinot, ML
      In vitro extrastriatal and striatal D-2 dopamine receptor blockade by amisulpride in schizophrenia

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    60. Siris, SG
      Suicide and schizophrenia

      JOURNAL OF PSYCHOPHARMACOLOGY
    61. Lara, DR; Brunstein, MG; Ghisolfi, ES; Lobato, MI; Belmonte-de-Abreu, P; Souza, DO
      Allopurinol augmentation for poorly responsive schizophrenia

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    62. Kasper, S; Quiner, S; Barnas, C; Fabisch, T; Haushofer, M; Sackel, C; Konig, P; Lingg, A; Platz, T; Rittmannsberger, H; Stuppack, C; Willeit, M; Zapotoczky, HG
      Zotepine in the treatment of acute hospitalized schizophrenic episodes

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    63. Berk, M; Ichim, C; Brook, S
      Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    64. Kane, J
      Progress defined - short-term efficacy, long-term effectiveness

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    65. Stirling, JD; Hellewell, JSE; Ndlovu, D
      Self-monitoring dysfunction and the positive symptoms of schizophrenia

      PSYCHOPATHOLOGY
    66. Lykouras, L; Oulis, P; Daskalopoulou, E; Psarros, K; Christodoulou, GN
      Clinical subtypes of schizophrenic disorders: A cluster analytic study

      PSYCHOPATHOLOGY
    67. Fernandez, OV; Giraldez, SL
      Efficacious psychological treatments for schizophrenia

      PSICOTHEMA
    68. Mooren, R; Verhoeven, WMA; Tuinier, S; van den Berg, YWMM; Fekkes, D; Pepplinkhuizen, L
      Olanzapine in relapsing schizophrenia. Efficacy and serotonergic parameters

      EUROPEAN JOURNAL OF PSYCHIATRY
    69. Kulhara, P; Chakrabarti, S
      Culture and schizophrenia and other psychotic disorders

      PSYCHIATRIC CLINICS OF NORTH AMERICA
    70. Apiquian, R; Fresan, A; Ulloa, RE; Garcia-Anaya, M; Loyzaga, C; Nicolini, H; Ortega-Soto, H
      Comparative study of depressed and non-depressed schizophrenic patients.

      SALUD MENTAL
    71. Paez, F; Apiquian, R; Fresan, A; Puig, A; Orozco, B; De la Fuente, JR; Sidenberg, D; Nicolini, H
      Dermatoglyphic study of positive and negative symptoms in schizophrenia

      SALUD MENTAL
    72. Schmidt, K; Nolte-Zenker, B; Patzer, J; Bauer, M; Schmidt, LG; Heinz, A
      Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence

      PHARMACOPSYCHIATRY
    73. Iwanami, A; Okajima, Y; Isono, H; Shinoda, J; Kasai, K; Hata, A; Fukuda, M; Nakagome, K; Kamijima, K
      Effects of risperidone on event-related potentials in schizophrenic patients

      PHARMACOPSYCHIATRY
    74. Sayed, MAN; Noda, Y; Hamdy, MM; Mamiya, T; Nagai, T; Furukawa, H; Nabeshima, T
      Enhancement of immobility induced by repeated phencyclidine injection: association with c-Fos protein in the mouse brain

      BEHAVIOURAL BRAIN RESEARCH
    75. Jeon, YW; Polich, J
      P300 asymmetry in schizophrenia: a meta-analysis

      PSYCHIATRY RESEARCH
    76. Kasckow, JW; Twamley, E; Mulchahey, JJ; Carroll, B; Sabai, M; Strakowski, SM; Patterson, T; Jeste, DV
      Health-related quality of well-being in chronically hospitalized patients with schizophrenia: comparison with matched outpatients

      PSYCHIATRY RESEARCH
    77. Lee, KH; Williams, LM; Loughland, CM; Davidson, DJ; Gordon, E
      Syndromes of schizophrenia and smooth-pursuit eye movement dysfunction

      PSYCHIATRY RESEARCH
    78. Moritz, S; Heeren, D; Andresen, B; Krausz, M
      An analysis of the specificity and the syndromal correlates of verbal memory impairments in schizophrenia

      PSYCHIATRY RESEARCH
    79. Gomez, JC; Crawford, AMK
      Superior efficacy of olanzapine over haloperidol: Analysis of patients with schizophrenia from a multicenter international trial

      JOURNAL OF CLINICAL PSYCHIATRY
    80. Sauriol, L; Laporta, M; Edwardes, MD; Deslandes, M; Ricard, N; Suissa, S
      Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: Evaluating the indirect approach

      CLINICAL THERAPEUTICS
    81. Cai, GQ; Li, T; Deng, D; Zhao, JH; Hu, X; Murray, RM; Liu, XH; Sham, PC; Collier, DA
      Affected sibling pair linkage analysis of qualitative and quantitative traits for schizophrenia on chromosome 22 in a Chinese population

      AMERICAN JOURNAL OF MEDICAL GENETICS
    82. Wadenberg, MLG; Browning, JL; Young, KA; Hicks, PB
      Antagonism at 5-HT2A receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    83. Gilvarry, CM; Russell, A; Jones, P; Sham, P; Hemsley, D; Murray, RM
      Verbal fluency in patients with schizophrenia and affective psychoses and their first-degree relatives

      PSYCHOLOGICAL MEDICINE
    84. Rodriguez-Ferrera, S; McCarthy, RA; McKenna, PJ
      Language in schizophrenia and its relationship to formal thought disorder

      PSYCHOLOGICAL MEDICINE
    85. Golightly, KL; Lloyd, JA; Hobson, JE; Gallagher, P; Mercer, G; Young, AH
      Acute tryptophan depletion in schizophrenia

      PSYCHOLOGICAL MEDICINE
    86. McIntosh, AM; Forrester, A; Lawrie, SM; Byrne, R; Harper, A; Kestelman, JN; Best, JJK; Miller, P; Johnstone, EC; Owens, DGC
      A factor model of the functional psychoses and the relationship of factorsto clinical variables and brain morphology

      PSYCHOLOGICAL MEDICINE
    87. Grunder, G; Vernaleken, I; Benkert, O
      Which properties make a neuroleptic "atypical"?

      NERVENARZT
    88. Goff, DC; Heckers, S; Freudenreich, O
      Schizophrenia

      MEDICAL CLINICS OF NORTH AMERICA
    89. Kotlicka-Antczak, M; Gmitrowicz, A; Sobow, TM; Rabe-Jablonska, J
      Obstetric complications and Apgar score in early-onset schizophrenic patients with prominent positive and prominent negative symptoms

      JOURNAL OF PSYCHIATRIC RESEARCH
    90. Nieuwenstein, MR; Aleman, A; de Haan, EHF
      Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies

      JOURNAL OF PSYCHIATRIC RESEARCH
    91. Zhang, ZJ; Peet, M; Ramchand, CN; Shah, S; Reynolds, GP
      Plasma homovanillic acid in untreated schizophrenia - relationship with symptomatology and sex

      JOURNAL OF PSYCHIATRIC RESEARCH
    92. de Vries, PJ; Honer, WG; Kemp, PM; McKenna, PJ
      Dementia as a complication of schizophrenia

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    93. Messias, E; Kirkpatrick, B
      Summer birth and deficit schizophrenia in the Epidemiological Catchment Area study

      JOURNAL OF NERVOUS AND MENTAL DISEASE
    94. Tek, C; Kirkpatrick, B; Kelly, C; McCreadie, RG
      Summer birth and deficit schizophrenia in Nithsdale, Scotland

      JOURNAL OF NERVOUS AND MENTAL DISEASE
    95. Mueser, KT; Sengupta, A; Schooler, NR; Bellack, AS; Xei, HY; Glick, ID; Keith, SJ
      Family treatment and medication dosage reduction in schizophrenia: Effectson patient social functioning, family attitudes, and burden

      JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY
    96. Watson, D
      Dissociations of the night: Individual differences in sleep-related experiences and their relation to dissociation and schizotypy

      JOURNAL OF ABNORMAL PSYCHOLOGY
    97. Slaghuis, WL; Bishop, AM
      Luminance flicker sensitivity in positive- and negative-symptom schizophrenia

      EXPERIMENTAL BRAIN RESEARCH
    98. Westerink, BHC; Kawahara, Y; De Boer, P; Geels, C; De Vries, JB; Wikstrom, HV; Van Kalkeren, A; Van Vliet, B; Kruse, CG; Long, SK
      Antipsychotic drugs classified by their effects on the release of dopamineand noradrenaline in the prefrontal cortex and striatum

      EUROPEAN JOURNAL OF PHARMACOLOGY
    99. Curran, MP; Perry, CM
      Amisulpride - A review of its use in the management of schizophrenia

      DRUGS
    100. Tapp, A; Kilzieh, N; Wood, AE; Raskind, M; Tandon, R
      Depression in patients with schizophrenia during an acute psychotic episode

      COMPREHENSIVE PSYCHIATRY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 15:12:55